Logo image of CAS.CA

CASCADES INC (CAS.CA) Stock Fundamental Analysis

TSX:CAS - Toronto Stock Exchange - CA1469001053 - Common Stock - Currency: CAD

11.44  -0.29 (-2.47%)

Fundamental Rating

3

Taking everything into account, CAS scores 3 out of 10 in our fundamental rating. CAS was compared to 9 industry peers in the Containers & Packaging industry. Both the profitability and financial health of CAS have multiple concerns. CAS is valued correctly, but it does not seem to be growing. Finally CAS also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CAS had positive earnings in the past year.
In the past year CAS had a positive cash flow from operations.
In multiple years CAS reported negative net income over the last 5 years.
Each year in the past 5 years CAS had a positive operating cash flow.
CAS.CA Yearly Net Income VS EBIT VS OCF VS FCFCAS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

1.2 Ratios

The Return On Assets of CAS (-1.54%) is worse than 77.78% of its industry peers.
CAS's Return On Equity of -4.39% is on the low side compared to the rest of the industry. CAS is outperformed by 77.78% of its industry peers.
CAS has a Return On Invested Capital of 3.66%. This is in the lower half of the industry: CAS underperforms 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CAS is significantly below the industry average of 8.97%.
The last Return On Invested Capital (3.66%) for CAS is above the 3 year average (3.08%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.54%
ROE -4.39%
ROIC 3.66%
ROA(3y)0.43%
ROA(5y)1.27%
ROE(3y)0.81%
ROE(5y)3.71%
ROIC(3y)3.08%
ROIC(5y)4.11%
CAS.CA Yearly ROA, ROE, ROICCAS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

1.3 Margins

With a Operating Margin value of 4.28%, CAS is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of CAS has remained more or less at the same level.
CAS has a Gross Margin of 37.86%. This is in the better half of the industry: CAS outperforms 77.78% of its industry peers.
In the last couple of years the Gross Margin of CAS has grown nicely.
Industry RankSector Rank
OM 4.28%
PM (TTM) N/A
GM 37.86%
OM growth 3Y-8.35%
OM growth 5Y0.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y35.97%
GM growth 5Y23.42%
CAS.CA Yearly Profit, Operating, Gross MarginsCAS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CAS is destroying value.
Compared to 1 year ago, CAS has more shares outstanding
CAS has more shares outstanding than it did 5 years ago.
CAS has a better debt/assets ratio than last year.
CAS.CA Yearly Shares OutstandingCAS.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CAS.CA Yearly Total Debt VS Total AssetsCAS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.66, we must say that CAS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.66, CAS is doing worse than 88.89% of the companies in the same industry.
The Debt to FCF ratio of CAS is 10.63, which is on the high side as it means it would take CAS, 10.63 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.63, CAS is doing worse than 77.78% of the companies in the same industry.
CAS has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
CAS has a worse Debt to Equity ratio (1.07) than 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 10.63
Altman-Z 1.66
ROIC/WACC0.62
WACC5.86%
CAS.CA Yearly LT Debt VS Equity VS FCFCAS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

CAS has a Current Ratio of 1.22. This is a normal value and indicates that CAS is financially healthy and should not expect problems in meeting its short term obligations.
CAS has a worse Current ratio (1.22) than 88.89% of its industry peers.
CAS has a Quick Ratio of 1.22. This is a bad value and indicates that CAS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CAS (0.56) is worse than 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.56
CAS.CA Yearly Current Assets VS Current LiabilitesCAS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for CAS have decreased strongly by -68.00% in the last year.
CAS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.41% yearly.
The Revenue has decreased by -0.15% in the past year.
The Revenue has been decreasing by -0.05% on average over the past years.
EPS 1Y (TTM)-68%
EPS 3Y-17.88%
EPS 5Y5.41%
EPS Q2Q%-38.64%
Revenue 1Y (TTM)-0.15%
Revenue growth 3Y-3.47%
Revenue growth 5Y-0.05%
Sales Q2Q%0.25%

3.2 Future

The Earnings Per Share is expected to grow by 10.91% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.41% on average over the next years.
EPS Next Y-39.99%
EPS Next 2Y21.17%
EPS Next 3Y11.88%
EPS Next 5Y10.91%
Revenue Next Year-0.4%
Revenue Next 2Y3.09%
Revenue Next 3Y2.41%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CAS.CA Yearly Revenue VS EstimatesCAS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
CAS.CA Yearly EPS VS EstimatesCAS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

CAS is valuated quite expensively with a Price/Earnings ratio of 28.60.
77.78% of the companies in the same industry are cheaper than CAS, based on the Price/Earnings ratio.
CAS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.21, the valuation of CAS can be described as very cheap.
CAS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CAS is cheaper than 77.78% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. CAS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 28.6
Fwd PE 7.21
CAS.CA Price Earnings VS Forward Price EarningsCAS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CAS's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CAS indicates a somewhat cheap valuation: CAS is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.92
EV/EBITDA 6.67
CAS.CA Per share dataCAS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)5.29
EPS Next 2Y21.17%
EPS Next 3Y11.88%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.09%, CAS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.07, CAS pays a bit more dividend than its industry peers.
CAS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 4.09%

5.2 History

The dividend of CAS is nicely growing with an annual growth rate of 24.66%!
CAS has paid a dividend for at least 10 years, which is a reliable track record.
CAS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)24.66%
Div Incr Years0
Div Non Decr Years23
CAS.CA Yearly Dividends per shareCAS.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of CAS are negative and hence is the payout ratio. CAS will probably not be able to sustain this dividend level.
The dividend of CAS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-64%
EPS Next 2Y21.17%
EPS Next 3Y11.88%
CAS.CA Yearly Income VS Free CF VS DividendCAS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

CASCADES INC

TSX:CAS (2/21/2025, 7:00:00 PM)

11.44

-0.29 (-2.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-07 2025-05-07
Inst Owners27.38%
Inst Owner ChangeN/A
Ins Owners11.62%
Ins Owner ChangeN/A
Market Cap1.16B
Analysts72
Price Target14.37 (25.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.09%
Yearly Dividend0.48
Dividend Growth(5Y)24.66%
DP-64%
Div Incr Years0
Div Non Decr Years23
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.44%
Min EPS beat(2)35.79%
Max EPS beat(2)67.08%
EPS beat(4)3
Avg EPS beat(4)29.61%
Min EPS beat(4)-84.43%
Max EPS beat(4)100%
EPS beat(8)7
Avg EPS beat(8)30.05%
EPS beat(12)10
Avg EPS beat(12)-7.64%
EPS beat(16)11
Avg EPS beat(16)-14.91%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-0.17%
Max Revenue beat(2)0.5%
Revenue beat(4)1
Avg Revenue beat(4)-2.46%
Min Revenue beat(4)-6.18%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-1.17%
Revenue beat(12)6
Avg Revenue beat(12)-0.5%
Revenue beat(16)8
Avg Revenue beat(16)-1.06%
PT rev (1m)12.67%
PT rev (3m)12.67%
EPS NQ rev (1m)13.64%
EPS NQ rev (3m)13.64%
EPS NY rev (1m)6.35%
EPS NY rev (3m)33.68%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)0.3%
Valuation
Industry RankSector Rank
PE 28.6
Fwd PE 7.21
P/S 0.25
P/FCF 5.92
P/OCF 3.23
P/B 0.68
P/tB 0.98
EV/EBITDA 6.67
EPS(TTM)0.4
EY3.5%
EPS(NY)1.59
Fwd EY13.86%
FCF(TTM)1.93
FCFY16.88%
OCF(TTM)3.54
OCFY30.99%
SpS45.83
BVpS16.91
TBVpS11.64
PEG (NY)N/A
PEG (5Y)5.29
Profitability
Industry RankSector Rank
ROA -1.54%
ROE -4.39%
ROCE 5.09%
ROIC 3.66%
ROICexc 3.69%
ROICexgc 4.28%
OM 4.28%
PM (TTM) N/A
GM 37.86%
FCFM 4.21%
ROA(3y)0.43%
ROA(5y)1.27%
ROE(3y)0.81%
ROE(5y)3.71%
ROIC(3y)3.08%
ROIC(5y)4.11%
ROICexc(3y)3.17%
ROICexc(5y)4.32%
ROICexgc(3y)3.7%
ROICexgc(5y)5.15%
ROCE(3y)4.29%
ROCE(5y)5.72%
ROICexcg growth 3Y-11.88%
ROICexcg growth 5Y-0.89%
ROICexc growth 3Y-10.74%
ROICexc growth 5Y0.54%
OM growth 3Y-8.35%
OM growth 5Y0.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y35.97%
GM growth 5Y23.42%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 10.63
Debt/EBITDA 3.85
Cap/Depr 58.42%
Cap/Sales 3.52%
Interest Coverage 250
Cash Conversion 75.05%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.56
Altman-Z 1.66
F-Score5
WACC5.86%
ROIC/WACC0.62
Cap/Depr(3y)146.99%
Cap/Depr(5y)122.77%
Cap/Sales(3y)8.66%
Cap/Sales(5y)7.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68%
EPS 3Y-17.88%
EPS 5Y5.41%
EPS Q2Q%-38.64%
EPS Next Y-39.99%
EPS Next 2Y21.17%
EPS Next 3Y11.88%
EPS Next 5Y10.91%
Revenue 1Y (TTM)-0.15%
Revenue growth 3Y-3.47%
Revenue growth 5Y-0.05%
Sales Q2Q%0.25%
Revenue Next Year-0.4%
Revenue Next 2Y3.09%
Revenue Next 3Y2.41%
Revenue Next 5YN/A
EBIT growth 1Y-32.42%
EBIT growth 3Y-11.54%
EBIT growth 5Y0.81%
EBIT Next Year243.58%
EBIT Next 3Y60.33%
EBIT Next 5Y35.27%
FCF growth 1Y529.03%
FCF growth 3Y-21.99%
FCF growth 5Y35.52%
OCF growth 1Y-23.34%
OCF growth 3Y-4.58%
OCF growth 5Y6.46%